A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms

被引:0
作者
Stocchi, Fabrizio [1 ,2 ]
Kulisevsky, Jaime [3 ]
Jost, Wolfgang H. [4 ]
机构
[1] Univ San Raffaele Rome, Dept Neurol, Rome, Italy
[2] Inst Res & Med Care IRCCS San Raffaele Rome, Dept Neurol, Rome, Italy
[3] Univ Autonoma Barcelona, Sant Pau Hosp, CIBERNED, Barcelona, Spain
[4] Parkinson Klin Ortenau, Wolfach, Germany
关键词
Parkinson's disease; levodopa; pain; depression; therapeutic goals; UPDATE; MOTOR;
D O I
10.1002/mdc3.70188
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Parkinson's disease (PD) is a neurodegenerative disorder associated with motor and nonmotor symptoms. Objectives: This study assesses levodopa dose management, the therapeutic goals of clinicians, the factors that influence clinicians' choice of therapy, and the role of nonmotor symptoms using real-world evidence from Germany, Italy, and Spain. Methods: To assess the management of unstable PD patients on levodopa-containing regimens, neurologists were asked to complete questionnaires (n = 181) and prospective electronic patient records (EPR) were collected (n = 2687). Neurologists were asked questions about their practice and approach to unstable PD patients. EPRs were completed by neurologists after each visit with patients, and the objectives of any changes to therapy were recorded. Results: Seventy-four percent of neurologists cited "improving motor symptoms" as the main objective for increasing daily levodopa dose. This was also the main objective when starting an add-on (50%) and the main reason for selecting a new add-on therapy (29%). In comparison, reducing nonmotor symptoms, depression, and pain was rarely cited as either the main or secondary objective for a therapy selection (15%, 9%, and 9%, respectively) even when over 60% of unstable patients had pain or depression and 29% had both. When the importance of add-on therapy features was rated, "improve quality of life (QoL)" had the highest average score. Improving nonmotor symptoms, pain, and depression was among the lowest-rated therapy feature. Conclusions: These findings suggest that improving motor symptoms is a key driver of therapeutic choice. In prioritizing motor symptoms, neurologists may unintentionally neglect nonmotor symptoms, despite most patients suffering from pain or depression.
引用
收藏
页数:11
相关论文
共 26 条
[1]   Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies [J].
Abusrair, Ali H. ;
Elsekaily, Walaa ;
Bohlega, Saeed .
TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2022, 12
[2]   Diagnosis and Treatment of Parkinson Disease A Review [J].
Armstrong, Melissa J. ;
Okun, Michael S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (06) :548-560
[3]   Association of Motor and Nonmotor Symptoms With Health-RelatedQuality of Life in a LargeOnline Cohort of People With Parkinson Disease [J].
Bock, Meredith A. ;
Brown, Ethan G. ;
Zhang, Li ;
Tanner, Caroline .
NEUROLOGY, 2022, 98 (22) :E2194-E2203
[4]  
Carroll V, 2021, AUST J GEN PRACT, V50, P812, DOI 10.31128/AJGP-07-21-6093
[5]   Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis [J].
Cattaneo, Carlo ;
Barone, Paolo ;
Bonizzoni, Erminio ;
Sardina, Marco .
JOURNAL OF PARKINSONS DISEASE, 2017, 7 (01) :95-101
[6]   Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease [J].
Church, Frank C. .
BIOMOLECULES, 2021, 11 (04)
[7]   The economic benefit of timely, adequate, and adherence to Parkinson's disease treatment: the Value of Treatment Project 2 [J].
Dodel, R. ;
Tinelli, M. ;
Deuschl, G. ;
Petersen, G. ;
Oertel, W. ;
Ahmerkamp-Boehme, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (02) :707-716
[8]   The Emerging Evidence of the Parkinson Pandemic [J].
Dorsey, E. Ray ;
Sherer, Todd ;
Okun, Michael S. ;
Bloem, Bastiaan R. .
JOURNAL OF PARKINSONS DISEASE, 2018, 8 :S3-S8
[9]   The Parkinson Pandemic-A Call to Action [J].
Dorsey, E. Ray ;
Bloem, Bastiaan R. .
JAMA NEUROLOGY, 2018, 75 (01) :9-10
[10]   Off-time Treatment Options for Parkinson's Disease [J].
Fabbri, Margherita ;
Barbosa, Raquel ;
Rascol, Olivier .
NEUROLOGY AND THERAPY, 2023, 12 (02) :391-424